FDA panel revisits Avandia; likely too late for di…

FDA panel revisits Avandia; likely too late for diabetes drug reut.rs/1b3NqT2

Content appearing on eMedicalNews is for information and educational purposes use only. It should not be used as a substitute for medical advice, diagnosis or treatment provided by a licensed healthcare professional. Please review any medical news or information this website with your own physician in order to obtain actual medical advice. Use of this web site constitutes acceptance of the Terms of Use and Privacy Policy.